Skip to content

Sustained effectiveness and safety of esketamine for major depressive disorder: a target trial simulation of real-world data.

Transl Psychiatry April 10, 2026 Peer reviewed DOI: 10.1038/s41398-026-04032-3 via PubMed Central

Abstract

Sustained effectiveness and safety of esketamine for major depressive disorder: a target trial simulation of real-world data.

Comments

No comments yet.

Log in to comment